Global Patient Blood Management Market

Patient Blood Management Market Size, Share, Growth Analysis, By Type(Instruments, Software and Consumables), By Application(Preoperative Anemia Management, Acute Blood Loss Management and Chronic Blood Loss Management), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35D2100 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 61 | Figures: 75

Patient Blood Management Market News

  • In June 2023, Haemonetics Corporation launched a new blood management software platform called HemAssist. This platform is designed to help hospitals improve their blood management practices by providing them with a centralized view of their blood inventory and transfusion data.
  • In May 2023, Terumo Corporation received FDA approval for its T-Cell Select blood processing device. This device is designed to remove T cells from blood products, which can help to reduce the risk of transfusion-related graft-versus-host disease (GVHD).
  • In April 2023, Cerus Corporation announced that it has entered into a strategic partnership with Octapharma. This partnership will allow Cerus to market and distribute its Abraxane blood salvage device in Europe.
  • In March 2023, Grifols International S.A. acquired Baxter International's blood plasma collection business. This acquisition will give Grifols a larger presence in the global blood plasma collection market.
  • In February 2023, Biosafe Blood Management Services announced that it has opened a new blood bank in New Delhi, India. This blood bank is designed to help meet the growing demand for blood products in India.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Patient Blood Management Market size was valued at USD 12.97 billion in 2022 and is poised to grow from USD 13.79 billion in 2023 to USD 22.48 billion by 2031, growing at a CAGR of 6.30% during the forecast period (2024-2031).

The global patient blood management market is highly competitive and dynamic, characterized by the presence of several key players operating in the healthcare industry. Patient blood management refers to a multidisciplinary approach that aims to optimize patient outcomes by effectively managing and preserving the patient's own blood. This includes strategies such as minimizing blood loss, optimizing red blood cell production, and utilizing alternative therapies to transfusion. 'Fresenius SE & Co. KGaA (Germany)', 'Haemonetics Corporation (US)', 'Terumo Corporation (Japan)', 'B. Braun Melsungen AG (Germany)', 'Bio-Rad Laboratories, Inc. (US)', 'LivaNova PLC (UK)', 'Medtronic PLC (Ireland)', 'Abbott Laboratories (US)', 'Grifols, S.A. (Spain)', 'F. Hoffmann-La Roche Ltd (Switzerland)', 'Danaher Corporation (US)', 'Immucor, Inc. (US)', 'BioMérieux SA (France)', 'Ortho Clinical Diagnostics (US)', 'Fresenius Kabi AG (Germany)', 'Kedrion S.p.A. (Italy)', 'Octapharma AG (Switzerland)', 'Beckman Coulter, Inc. (US)', 'Siemens Healthineers AG (Germany)', 'Quidel Corporation (US)'

The field of transfusion medicine has experienced notable progress, marked by the emergence of novel techniques and technologies for blood management. These advancements have significantly improved the safety and effectiveness of blood transfusions, thereby encouraging the adoption of patient blood management practices.

One significant market trend in the global patient blood management market is the increasing focus on personalized and evidence-based approaches to optimize blood transfusion practices. This trend emphasizes the importance of tailoring blood transfusion strategies to individual patients based on their specific needs and clinical conditions, rather than adopting a one-size-fits-all approach. Healthcare providers and organizations are recognizing the potential risks and complications associated with unnecessary blood transfusions, such as transfusion reactions, infections, and increased healthcare costs.

North America dominated the global patient blood management market. North America holds a significant share in the market due to the presence of advanced healthcare infrastructure, well-established healthcare systems, and a high level of awareness about patient blood management practices. Countries like the US and Canada have implemented stringent regulations and guidelines to promote safe and effective blood management, driving the market growth in the region. Additionally, technological advancements and a strong focus on research and development contribute to the dominance of North America in the patient blood management market.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Blood Collection Tubes Market
Buy Now GET FREE SAMPLE
Blood Testing Market
Buy Now GET FREE SAMPLE
Blood Screening Market
Buy Now GET FREE SAMPLE
Bleeding Disorders Treatment Market
Buy Now GET FREE SAMPLE
Patient Flow Management Solutions Market
Buy Now GET FREE SAMPLE
Medication Management Market
Buy Now GET FREE SAMPLE
Medical Case Management Market
Buy Now GET FREE SAMPLE
Patient Temperature Management Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Patient Blood Management Market

Report ID: SQMIG35D2100

$5,300
BUY NOW GET FREE SAMPLE